A study led by the University of Barcelona and the Spanish National Research Council’s Institute for Advanced Chemistry of Catalonia (IQAC – CSIC) presents a new therapeutic tool capable of inhibiting the proliferation of the SARS-CoV-2 virus that causes COVID-19.